Form 990 for tax year 2023
Filed by CONGENITAL HYPERINSULINISM INTERNATIONAL.
Totals
- Total revenue
- $1,150,291
- Total expenses
- $1,043,446
- Contributions and grants received
- $463,103
- Grants paid
- $88,125
- Program service revenue
- $694,586
- Investment income
- $25,235
- Other revenue
- -$32,633
- Total assets, end of year
- $1,803,323
- Total liabilities, end of year
- $98,789
- Net assets or fund balances, end of year
- $1,704,534
- Program services expenses (Part IX)
- $919,830
- Management and general expenses
- $41,912
- Fundraising expenses
- $81,704
- Program service expenses (Part III)
- $919,830
Program services were 88.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c , Fundraising events
$174,266
-
1f , All other contributions, gifts and grants
$288,837
-
2a , Program service revenue: CONFERENCES
total $235,645 · excluded $235,645
-
2b , Program service revenue: RESEARCH
total $458,941 · excluded $458,941
-
3 , Investment income
total $25,235 · related or exempt $25,235
-
4 , Income from investment of tax-exempt bond proceeds
total $0
-
5 , Royalties
total $0
-
6d , Net rental income or loss
total $0
-
7d , Net gain or loss
total $0
-
8a , Fundraising events: gross income
$33,000
-
8a , Fundraising events: contributions included on line 1c
$174,266
-
8b , Fundraising events: direct expenses
$66,450
-
8c , Net income from fundraising events
total -$33,450
-
9c , Net income from gaming
total $0
-
10c , Net income from sales of inventory
total $0
-
11a , Other revenue: Misc revenue
total $817 · related or exempt $817
-
11e , Other revenue, total
$817
Functional expenses
Part IX, the statement of functional expenses.
-
1 , Grants to domestic organizations and governments
total $41,650 · program services $41,650
-
2 , Grants to domestic individuals
total $0
-
3 , Grants to foreign organizations and individuals
total $46,475 · program services $46,475
-
4 , Benefits paid to or for members
total $0
-
5 , Compensation of officers, directors and key employees
total $269,704 · program services $232,042 · management and general $17,185 · fundraising $20,477
-
6 , Compensation of disqualified persons
total $0
-
7 , Other salaries and wages
total $170,143 · program services $140,360 · fundraising $29,783
-
8 , Pension plan contributions
total $0
-
9 , Other employee benefits
total $17,185 · program services $14,551 · management and general $670 · fundraising $1,964
-
10 , Payroll taxes
total $38,046 · program services $32,211 · management and general $1,488 · fundraising $4,347
-
11a , Fees: management
total $0
-
11b , Fees: legal
total $0
-
11c , Fees: accounting
total $19,129 · program services $3,177 · management and general $12,776 · fundraising $3,176
-
11d , Fees: lobbying
total $0
-
11e , Fees: professional fundraising services
total $0
-
11f , Fees: investment management
total $0
-
11g , Fees: other
total $28,568 · program services $18,568 · fundraising $10,000
-
12 , Advertising and promotion
total $0
-
13 , Office expenses
total $12,345 · program services $5,343 · management and general $3,631 · fundraising $3,371
-
14 , Information technology
total $0
-
15 , Royalties
total $0
-
16 , Occupancy
total $392 · program services $317 · management and general $37 · fundraising $38
-
17 , Travel
total $26,555 · program services $26,555
-
18 , Travel or entertainment for public officials
total $0
-
19 , Conferences, conventions and meetings
total $219,968 · program services $219,968
-
20 , Interest
total $0
-
21 , Payments to affiliates
total $0
-
22 , Depreciation, depletion and amortization
total $1,875 · program services $1,875
-
23 , Insurance
total $5,963 · program services $2,391 · management and general $1,755 · fundraising $1,817
-
24a , Other expenses: PROGRAM COSTS AND MATERIALS
total $99,149 · program services $99,149
-
24b , Other expenses: TELECOMMUNICATION & TECHNOLOGY
total $18,061 · program services $8,843 · management and general $3,723 · fundraising $5,495
-
24c , Other expenses: PROJECT EXPENSES
total $16,911 · program services $16,911
-
24d , Other expenses: DUES AND SUBSCRIPTIONS
total $6,130 · program services $5,517 · management and general $307 · fundraising $306
-
24e , All other expenses
total $5,197 · program services $3,927 · management and general $340 · fundraising $930
Balance sheet
Part X, book values.
-
1 , Cash, non-interest-bearing
beginning of year $1,510,108 · end of year $1,595,342
-
2 , Savings and temporary cash investments
end of year $0
-
3 , Pledges and grants receivable
beginning of year $116,060 · end of year $64,759
-
4 , Accounts receivable
end of year $0
-
5 , Loans and receivables from officers and key people
end of year $0
-
6 , Loans and receivables from disqualified persons
end of year $0
-
7 , Other notes and loans receivable
end of year $0
-
8 , Inventories for sale or use
end of year $0
-
9 , Prepaid expenses and deferred charges
beginning of year $18,147 · end of year $31,746
-
10c , Land, buildings and equipment, net
end of year $0
-
11 , Investments: publicly traded securities
end of year $0
-
12 , Investments: other securities
end of year $0
-
13 , Investments: program-related
end of year $0
-
14 , Intangible assets
end of year $111,476
-
15 , Other assets
end of year $0
-
17 , Accounts payable and accrued expenses
beginning of year $46,626 · end of year $98,789
-
27 , Net assets without donor restrictions
beginning of year $1,562,689 · end of year $1,669,534
-
28 , Net assets with donor restrictions
beginning of year $35,000 · end of year $35,000
Mission and programs · 2023
Mission
Congenital Hyperinsulinism International (CHI) is dedicated to creating awareness, providing support and the advancement of research to improve the lives of those impacted by congenital hyperinsulinism and other rare hypoglycemia disorders globally. CHI provides education, information and support to families of diagnosed children and adults living with the consequences of the condition. CHI works to promote knowledge and awareness of the disorder as it leads to timely diagnosis and decreases death and brain damage, better care and better neurological outcomes. CHI supports research and development for a better understanding of the condition, leading to a better quality of life, better treatments and management of the condition, and ultimately, a cure.
Activities or mission (Part I)
Congenital Hyperinsulinism International's mission is to improve the lives of people living with congenital hyperinsulinism (or its consequences),a disorder that causes severe hypoglycemia that can lead to seizures,brain damage,or death, if untreated.
-
CHI supports research and development to better understand, treat, manage and hopefully cure HI. CHI shares the patient perspective with researchers and members of the biopharmaceutical industry to accelerate the development of patient-centered treatments. CHI is part of the Million Dollar Bike Ride grant program with the University of Pennsylvania's Center for Orphan Diseases; a pilot research grant is offered each year for an innovative, preclinical or clinical study with the potential to lead to a better HI treatment, a cure for HI, or improvement in the quality of life for those affected by HI. CHI conducts the HI Global Registry (HIGR) research project. HIGR provides a convenient online platform for the HI patient community to share their experiences of living with HI. With permission from the patient families, MaxHIGR provides complementary data from the physician perspective. By participating in the HI Global Registry, the patient community helps themselves and researchers better understand HI to advance better treatments, a potential cure, and more timely and accurate diagnoses. A HIGR report is published each year by the CHI staff. Scholars and researchers may request deidentified data for their research projects. In 2023, CHI continued to lead the Collaborative Research Network (CRN), , a project of CHI dedicated to the development of faster and more accurate diagnoses, new evidence-based treatments and cures, standardized clinical guidelines, and increased and improved access to treatment, medication, devices, and supplies. This ambitious project includes working groups focused on different aspects of a prioritized research agenda (PRA) developed by the CRNs members including 55 leading researchers, clinicians, and patient advocates from 16 countries The CRN members have been focused on the top priorities identified in the PRA: Newborn Screening (Diagnose all babies with congenital hyperinsulinism in a timely manner); Glucose as a Vital Sign (Increase awareness and timely diagnosis of HI); Care Guidelines (Create and disseminate continually evolving global care guidelines); Natural History (Build a robust registry that collects patient-reported, physician, and real-world data to provide a foundation for HI natural history); Continuous Glucose Monitoring (Create principles for Draft guidelines on CGM use in HI patients)The first-ever international hyperinsulinism guidelines were published in July 2023. These guidelines are a collaboration of work by HI experts around the world, including many who are part of the CHI Collaborative Research Network and CHI staff. Patient and caregiver representatives of the CHI Congenital Hyperinsulinism Collaborative Research Network provided the patient perspective. CHI continues to support the Open Hyperinsulinism Genes Program in partnership with the University of Exeter in the UK which is the first point-of-need international genetic testing service for HI that is also accelerating scientific knowledge through the creation of a self-sustaining, research gene discovery pipeline. Through December 2023, 894 samples from individuals affected by Congenital Hyperinsulinism and 630 samples from family members from 61 countries on 5 continents have been tested. In 2023, CHI continued to support the CHI Centers of Excellence Designation. Six centers were granted the designation and recognized as multi-disciplinary clinical and research centers in the field of congenital hyperinsulinism in 2021. The goals of this program are to make it easier for patient families to access care at leading hospitals, encourage patient-focused standards at the leading hospitals, foster a pipeline of expert clinicians and researchers, and to encourage collaboration among researchers, clinicians, and patient leaders and advocates.
Expenses $423,589
-
CHI advocates on behalf of HI families all over the world for access to quality treatment, medication, and supplies. CHI provides opportunities for affected families to emotionally support each other because the home care medical management of HI is often complicated and difficult. CHI offers online forums, and CHI staff and volunteers are available by telephone, online and in-person for support. CHI establishes funds at hospitals to support families from out of town who must travel to centers of excellence for patient care.
Expenses $274,496
-
CHI increases awareness of HI in order to improve timely diagnosis among the public and medical personnel who have a direct opportunity to detect it, to decrease adverse neurological outcomes and death. To that end, CHI spreads awareness of HI with ongoing campaigns on social media, the CHI website and blog, CHI posters in 24 languages, CHI brochures, through direct mail and email, and at meetings and conferences. CHI provides educational resources and holds onferences and meetings on HI for patients, families, medical professionals, school personnel,and rare disease industry members. To date, CHI has held 31 family and research meetings and conferences with presentations from academic researchers, members of advocacy organizations, HI patients and families, and biotechnology companies.
Expenses $221,745
As filed on the 2023 return.
Listed in Part VII
-
Julie RaskinJULIE RASKIN
CEO
- Total calculated
- $103,704
- From this org
- $103,704
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
-
Tai PasquiniTAI PASQUINI
CRO
- Total calculated
- $86,000
- From this org
- $86,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
-
Jennifer SchmittJENNIFER SCHMITT
COO
- Total calculated
- $80,000
- From this org
- $80,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
-
Sheila BoseSHEILA BOSE
President
- Total calculated
- $0
- Hours/week
- 6
-
Turaya Bryant KamauTURAYA BRYANT KAMAU
Secretary
- Total calculated
- $0
- Hours/week
- 1
-
Erin GreavesERIN GREAVES
Director
- Total calculated
- $0
- Hours/week
- 1
-
Laura SullivanLAURA SULLIVAN
Director
- Total calculated
- $0
- Hours/week
- 1
-
Mason SmithMASON SMITH
Treasurer
- Total calculated
- $0
- Hours/week
- 2
-
Pam WilliamsPAM WILLIAMS
Director
- Total calculated
- $0
- Hours/week
- 1
-
Julie SheldonJULIE SHELDON
Vice President
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
UNIVERSITY OF PENNSYLVANIA
$31,650
RESEARCH
Fundraising and gaming
From Schedule G of this return, as filed.
- Had an agreement with a professional fundraiser (line 2a)
- No
Fundraising events (Part II)
Part II has at most four columns: the two largest events, the rest together, and the total.
| Line | Event 1 SUGAR SOIREE | Total |
|---|---|---|
| Gross receipts (line 1) | $207,266 | $207,266 |
| Less contributions (line 2) | $174,266 | $174,266 |
| Gross income (line 3) | $33,000 | $33,000 |
| Cash prizes (line 4) | — | — |
| Noncash prizes (line 5) | — | — |
| Rent and facility costs (line 6) | $66,450 | $66,450 |
| Food and beverages (line 7) | — | — |
| Entertainment (line 8) | — | — |
| Other direct expenses (line 9) | — | — |
- Direct expenses (line 10)
- $66,450
- Net income (line 11)
- -$33,450
Activities outside the United States
From Schedule F of this return, as filed.
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| SRI LANKA | $7,369 | Wire | — | — | — |
| UK | $34,106 | Wire | — | — | — |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- —
- Other grantees (Part II line 3)
- 2
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 8 October 2024
- IRS schema version
- 2023v5.1
- Source object
- 202402869349300315
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.